Back to results
US 2023/0142780 A1Published application
Use of viral vectors for coronavirus vaccine production
Assignees4MVac LLC, The Trustees of the University of Pennsylvania, Johnson & Johnson
InventorsHansell Hall Stedman, Geoffrey Tabin, Charles R. Bridges
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions that includes AAVs and AAV vectors that include a sequence encoding a SARS-CoV-2 polypeptide or a fragment thereof. Also provided herein are methods and materials for making and using AAVs and AAV vectors to generate immunity to a coronavirus in a subject.
Claims65
An adeno-associated virus (AAV) vector comprising a sequence encoding a SARS-CoV-2 polypeptide or a fragment thereof.
A vector comprising a sequence encoding a SARS-CoV-2 polypeptide or a fragment thereof.
Dependencies are inferred from the claim text.